Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory coronavirus 2 (SARS-COV-2) is a significant threat to global health security. Till date, no completely effective drug or vaccine is available to cure COVID-19. Therefore, an effective vaccine against SARS-COV-2 is crucially needed. This study was conducted to design an effective multiepitope based vaccine (MEV) against SARS-COV-2. Seven highly antigenic proteins of SARS-COV-2 were selected as targets and different epitopes (B-cell and T-cell) were predicted. Highly antigenic and overlapping epitopes were shortlisted. Selected epitopes indicated significant interactions with the HLA-binding alleles and 99.93% coverage of the world’s population. Hence, 505 amino acids long MEV was designed by connecting 16 MHC class I and eleven MHC class II epitopes with suitable linkers and adjuvant. MEV construct was non-allergenic, antigenic, stable and flexible. Furthermore, molecular docking followed by molecular dynamics (MD) simulation analyses, demonstrated a stable and strong binding affinity of MEV with human pathogenic toll-like receptors (TLR), TLR3 and TLR8. Finally, MEV codons were optimized for its in silico cloning into Escherichia coli K-12 system, to ensure its increased expression. Designed MEV in present study could be a potential candidate for further vaccine production process against COVID-19. However, to ensure its safety and immunogenic profile, the proposed MEV needs to be experimentally validated.
【초록키워드】 COVID-19, coronavirus disease, Coronavirus disease 2019, Vaccine, coronavirus, pandemic, molecular docking, molecular dynamics, Toll-like receptor, binding affinity, Protein, Epitopes, Coverage, amino acids, target, MHC class I, adjuvant, targets, molecular, T-cell, respiratory, epitope, global health security, B-cell, TLR3, Amino acid, In silico cloning, Escherichia coli, followed by, overlapping, increased expression, antigenic, antigenic proteins, Escherichia coli K-12 system, HLA-binding alleles, human pathogenic toll-like receptors, immunogenic profile, MEV codons, MEV construct, MHC class II epitopes, non-allergenic, Selected epitopes, severe acute respiratory coronavirus, TLR8, pathogenic, significant interaction, vaccine production, MHC class, multiepitope based vaccine, TLR, effective, Respiratory Coronavirus, linker, K-12, flexible, selected, predicted, caused, indicated, conducted, demonstrated, Till, analyses, highly antigenic, HLA-binding allele, MEV, MEV codon, vaccine against SARS-COV-2, 【제목키워드】 in silico, multiepitope based vaccine, approach, MEV,